SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0000935836-16-001129
Filing Date
2016-09-23
Accepted
2016-09-23 16:11:54
Documents
1

Document Format Files

Seq Description Document Type Size
1 tobira13g.htm SC 13G 49778
  Complete submission text file 0000935836-16-001129.txt   51598
Mailing Address 701 GATEWAY BLVD SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 701 GATEWAY BLVD SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-741-6625
Tobira Therapeutics, Inc. (Subject) CIK: 0001311596 (see all company filings)

IRS No.: 030422069 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-87592 | Film No.: 161899938
SIC: 2834 Pharmaceutical Preparations

Mailing Address 919 NW BOND STREET SUITE 204 BEND OR 97703
Business Address 919 NW BOND STREET SUITE 204 BEND OR 97703 541-647-5664
STONEPINE CAPITAL, L.P. (Filed by) CIK: 0001370042 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G